Hansoh Pharmaceutical Group Company Limited (simplified Chinese: 翰森制药集团有限公司; traditional Chinese: 翰森製藥集團有限公司; pinyin: Hànsēn Zhìyào Jítuán Yǒuxiàn Gōngsī) is a pharmaceutical company that manufactures and sells various types of medicine in mainland China.
[1] It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair.
[3] It is the largest psychotropic drug producer in China.
[4] Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange (SEHK: 3692) on 14 June 2019.
[5][6][7][8] In August 2022, it was announced that the company's stock would be added to the Hang Seng Index.